Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 6942, September 1, 2008. doi: 10.1158/0008-5472.CAN-08-0347
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lange, K.
Right arrow Articles by Orend, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lange, K.
Right arrow Articles by Orend, G.

Cell, Tumor, and Stem Cell Biology

Combined Lysophosphatidic Acid/Platelet-Derived Growth Factor Signaling Triggers Glioma Cell Migration in a Tenascin-C Microenvironment

Katrin Lange1, Martial Kammerer1, Falk Saupe2, Monika E. Hegi3,4, Stefan Grotegut5, Erika Fluri1 and Gertraud Orend1,2

1 Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; 2 Institute National de la Santé et de la Recherche Médicale, Strasbourg, France; 3 Laboratory of Tumor Biology and Genetics, Centre Universitaire Romand de Neurochirurgie and University of Lausanne, Lausanne, Switzerland; 4 National Center of Competence in Research Molecular Oncology, Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland; and 5 Sidney Kimmel Cancer Center, San Diego, California

Requests for reprints: Gertraud Orend, Institut National de la Santé et de la Recherche Médicale U682, Faculté de Medicine, Université Louis Pasteur, 3 Avenue Molière, 67200 Strasbourg, France. Phone: 33-3-88-27-53-55; Fax: 33-3-88-26-35-38; E-mail: gertraud.orend{at}inserm.u-strasbg.fr.

Key Words: Tumor microenvironment • glioma • stem cell niche • wound healing • tenascin-C • fibronectin • LPA • PDGF • syndecan-4 • paxillin • syndesmos • tropomyosin

The antiadhesive extracellular matrix molecule tenascin-C abrogates cell spreading on fibronectin through competitive inhibition of syndecan-4, thereby preventing focal adhesion kinase (FAK) activation and triggering enhanced proteolytic degradation of both RhoA and tropomyosin 1 (TM1). Here, we show that simultaneous signaling by lysophosphatidic acid (LPA) and platelet-derived growth factor (PDGF) initiates glioma cell spreading and migration through syndecan-4–independent activation of paxillin and FAK and by stabilizing expression of RhoA, TM1, TM2, and TM3. By using gene silencing methods, we show that paxillin, TM1, TM2, and TM3 are essential for LPA/PDGF-induced cell spreading on a fibronectin/tenascin-C (FN/TN) substratum. LPA/PDGF-induced cell spreading and migration on FN/TN depends on phosphatidylinositol 3-kinase, RhoKinase, and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 but is independent of phospholipase C and Jun kinase. RNA microarray data reveal expression of tenascin-C, PDGFs, LPA, and the respective receptors in several types of cancer, suggesting that the TN/LPA/PDGF axis exists in malignant tumors. These findings may in turn be relevant for diagnostic or therapeutic applications targeting cancer. [Cancer Res 2008;68(17):6942–52]




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Nazeer, M. G. Janech, J. J.-C. Lin, K. J. Ryan, J. M. Arthur, and M. N. Budisavljevic
Changes in protein profiles during course of experimental glomerulonephritis
Am J Physiol Renal Physiol, January 1, 2009; 296(1): F186 - F193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.